Consent to the Distribution of a New Medicine Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Inactivated influenza (split virion) 15 mcg of haemaglutinin for each of three recommended strains Solution for injection Connaught Laboratories Inc., Swiftwater, Pennsylvania, United States of America Fluzone Codeine phosphate 15 mg, 30 mg, 60 mg Note: Not to be marketed as substitutable for any other codeine phosphate product as if the two (2) products were bioequivalent. Tablets Douglas Pharmaceuticals Limited, Technical Division, Mount Roskill, Auckland Ciprofloxacin hydrochloride 0.3% Ophthalmic solution S A Alcorn-Couvreur N V., Puurs, Belgium Ciloxan Eye Drops Recombinant factor VIII 250IU/2.5 ml, 500IU/5 ml, 1000IU/10 ml Injection Bayer AG, Leverkusen, Germany Kogenate for injection Sodium chloride 0.35% w/w, hydroxyethylcellulose 0.44% w/w Ophthalmic solution (eye drops) Smith & Nephew Pharmaceuticals Limited, Harold Hill, Romford, Essex, England Minims Artificial Tears Bisoprolol hemifumarate 5 mg, 10 mg Tablets Cyanamid of Great Britain Limited, Gosport, Hants, England Monocor Dated this 22nd day of November 1993. C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.